To confirm this, AML cells were cultured with gilteritinib, TNFα, and gilteritinib in combination with BAY 11–7082 (an NF-κB inhibitor that inhibits TNFα-induced IκBα phosphorylation). Here, NFKBIA is linked to acute myeloid leukemia.